| rs228139 |
chr6 |
55628283 |
0.000321 |
G |
T |
Suicide attempts in bipolar disorder |
BMP5 |
intron |
21423239
|
| rs228140 |
chr6 |
55628344 |
0.000075 |
C |
T |
Personality dimensions |
BMP5 |
intron |
18957941
|
| rs228140 |
chr6 |
55628344 |
0.0000576 |
C |
T |
Receptive language ability |
BMP5 |
intron |
24687471
|
| rs228144 |
chr6 |
55631762 |
0.00000986 |
G |
A |
Child behavior checklist/1.5-5 pervasive developmental problems |
BMP5 |
intron |
23049896
|
| rs228146 |
chr6 |
55636255 |
0.0000389 |
C |
A |
Information processing speed |
BMP5 |
intron |
21130836
|
| rs228146 |
chr6 |
55636255 |
0.000052 |
C |
A |
Post-operative nausea and vomiting |
BMP5 |
intron |
21694509
|
| rs10948955 |
chr6 |
55687414 |
0.0000174 |
C |
T |
Post-operative nausea and vomiting |
BMP5 |
intron |
21694509
|
| rs9475417 |
chr6 |
55688361 |
0.000451 |
A |
G |
Response to taxane treatment (placlitaxel) |
BMP5 |
intron |
23006423
|
| rs3823039 |
chr6 |
55689305 |
0.0003227 |
A |
G |
Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) |
BMP5 |
intron |
23233654
|
| rs3823039 |
chr6 |
55689305 |
0.000323 |
A |
G |
Methotrexate clearance (acute lymphoblastic leukemia) |
BMP5 |
intron |
23233662
|
| rs1447133 |
chr6 |
55694267 |
0.000339 |
C |
T |
Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) |
BMP5 |
intron |
23233654
|
| rs1447133 |
chr6 |
55694267 |
0.000339 |
C |
T |
Methotrexate clearance (acute lymphoblastic leukemia) |
BMP5 |
intron |
23233662
|
| rs17734678 |
chr6 |
55695376 |
0.0003437 |
A |
G |
Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) |
BMP5 |
intron |
23233654
|
| rs17734678 |
chr6 |
55695376 |
0.000344 |
A |
G |
Methotrexate clearance (acute lymphoblastic leukemia) |
BMP5 |
intron |
23233662
|
| rs17678251 |
chr6 |
55708204 |
0.000387 |
C |
A |
Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) |
BMP5 |
intron |
23233654
|
| rs17678251 |
chr6 |
55708204 |
0.000387 |
C |
A |
Methotrexate clearance (acute lymphoblastic leukemia) |
BMP5 |
intron |
23233662
|
| rs921126 |
chr6 |
55709741 |
0.0005158 |
C |
T |
Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) |
BMP5 |
intron |
23233654
|
| rs921126 |
chr6 |
55709741 |
0.000516 |
C |
T |
Methotrexate clearance (acute lymphoblastic leukemia) |
BMP5 |
intron |
23233662
|
| rs9475436 |
chr6 |
55734220 |
0.000206 |
C |
T |
Alzheimer's disease (late onset) |
BMP5 |
intron |
21379329
|
| rs3734444 |
chr6 |
55739553 |
0.0000413 |
A |
G |
Alzheimer's disease (late onset) |
BMP5 |
cds-synon |
21379329
|